Dublin, Aug. 10, 2018 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma Companies, 2017 - The Patient Perspective of 101 Mental Health Patient Groups - Mental Health Edition" report has been added to ResearchAndMarkets.com's offering
State of relationships between mental-health patient groups and the pharmaceutical industry
Mental-health patient groups provide pivotal support to patients who are experiencing issues of mental health. These patient groups will also typically reach out, and offer help, to the families, carers, and friends of the individuals with a mental-health issue (indeed, some mental-health patient groups specialise in representing the interests of just these latter stakeholders).
Mental-health patient groups train carers, family, and friends in helping with people living with a mental-health issue - and even train health professionals. In addition, mental-health patient organisations do much to raise public awareness of the prejudice shown to people with a mental-health issue.
Yet, despite the important role played by this component of the patient movement, data from the mental-health element of the 2017 Corporate-Reputation survey confirms that levels of engagement between pharma companies and mental-health patient groups are not extensive (except in the case of a few companies - particularly, Janssen).
So, how did the companies perform at corporate reputation in 2017, in the viewpoints of mental-health patient groups?
Ranking at corporate reputation is measured by patient groups familiar with a company.
Key Topics Covered:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/research/cw2hgx/corporate?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.